FRANCISCAN HEALTH MOORESVILLE
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $506K
- Transactions
- 94
- Companies
- 17
- Average per transaction
- $5,381
Who reported the payments
| Novartis | $127,259 |
| Takeda Pharmaceuticals U.S.A., Inc. | $89,378 |
| Pfizer | $58,742 |
| Janssen Research & Development, LLC | $49,681 |
| Bristol Myers Squibb | $46,850 |
| E.r. Squibb & Sons, L.L.C. | $36,965 |
| Livanova USA, Inc. | $27,166 |
| EMD Serono, Inc. | $19,822 |
| Depuy Synthes Products, Inc. | $15,411 |
| Esperion Therapeutics, Inc. | $8,140 |
| Edwards Lifesciences | $7,000 |
| Medical Device Business Services, Inc. | $6,500 |
| Stryker | $6,165 |
| Zimmer Biomet | $3,316 |
| Olympus America Inc. | $1,429 |
| Linvatec Corporation | $1,125 |
| Incyte Corporation | $823 |